SCHEMBL4590741

SCHEMBL4590741

CN(C)CCN(C)CC(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.48
CA2 P00918 1/20 0.48
CA3 P07451 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA5A P35218 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
MAPT P10636 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRM3 P20309 1/20 0.33
CHRNA4 P43681 1/20 0.33
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15809609 0.86 LTA4H (0.39) CA12CA2CA3CA4CA6
SCHEMBL23049142 0.82 CA12 (0.50) CA12CA2CA3CA4CA6
SCHEMBL13407442 0.81 LMNA (0.37) CHRNB2CHRNA4ALDH1A1CYP1A2TDP1
SCHEMBL21320204 0.80
SCHEMBL8429697 0.80
SCHEMBL8416609 0.80
SCHEMBL26046084 0.79 BHMT (0.32) ALDH1A1CYP1A2TDP1BHMTHSD17B10
SCHEMBL15693981 0.78
SCHEMBL16385287 0.78 CA12 (0.40) CA12CA2CA3CA4CA6
SCHEMBL24632215 0.78 CHRM2 (0.31) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881842-A1 USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF LUNG INJURIES IMBA-Institut für Molekulare Biotechnologie GmbH (AT) 2008-01-30 EP claimed
WO-2006122819-A1 USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF LUNG INJURIES IMBA-INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) 2006-11-23 WO claimed
EP-1723962-A1 Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries IMBA-Institut für Molekulare Biotechnologie GmbH (AT) 2006-11-22 EP claimed
EP-1881842-A1 USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF LUNG INJURIES IMBA-Institut für Molekulare Biotechnologie GmbH (AT) 2008-01-30 EP disclosed
WO-2006122819-A1 USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF LUNG INJURIES IMBA-INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) 2006-11-23 WO disclosed
EP-1723962-A1 Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries IMBA-Institut für Molekulare Biotechnologie GmbH (AT) 2006-11-22 EP disclosed